Ye Zhou, Hu Qi-Xin, Wei Ming-Liang, Chen Ji-Dong, Shi Jia, Yang Ning-Rong, Jiang Lu, Chen Jian, Chen Zhi-Yuan, Yu Wei-Min, Xiao Yu, Qian Kai-Yu, Xu Zilin, Wang Zhong, Qi Wen-Lu, Xiao Xin-Yi, Duan Yu-Yu, Xiao Yong, Li Lian-Yun, Ju Lin-Gao, Chen Ming-Kai, Wu Min
State Key Laboratory of Metabolism and Regulation in Complex Organisms, Frontier Science Center for Immunology and Metabolism, Hubei Key Laboratory of Cell Homeostasis, Hubei Key Laboratory of Developmentally Originated Disease, College of Life Sciences, Taikang Center for Life and Medical Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, 430072, China.
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, 430072, China.
Adv Sci (Weinh). 2025 Jul;12(28):e04532. doi: 10.1002/advs.202504532. Epub 2025 May 20.
Lipid storage and epigenetic dysregulation are key features for clear cell renal carcinoma (ccRCC). However, the interplay between fatty acid metabolism and epigenetics in ccRCC remains to be further demonstrated. Here, the landscape of active enhancers is profiled in paired ccRCC samples and identifies 10171 gain variant enhancer loci (VELs) in the tumor tissues. Experimental validation reveals the enhancers targeting FABP5, FABP6, LPCAT1, MET, SEMA5B, SH3GL1, SNX33, and RHBDF2 are oncogenic. Further studies in organoids and animal models prove FABP5 as an oncogene. HIF-2α and ZNF692 transcription factors regulate FABP5 expression through directly binding to its promoter and enhancer. FABP5 is essential for the lipid droplet formation driven by HIFs and critical for H3K27ac and enhancer activity in ccRCC cells. Thus, the study has identified potential targets for drug design and diagnosis and discovered the function of a feedback loop between epigenetics and lipid metabolism regulated by FABP5 in ccRCC.
脂质储存和表观遗传失调是肾透明细胞癌(ccRCC)的关键特征。然而,脂肪酸代谢与ccRCC表观遗传学之间的相互作用仍有待进一步证实。在此,对配对的ccRCC样本中的活性增强子图谱进行了分析,并在肿瘤组织中鉴定出10171个获得性变异增强子位点(VELs)。实验验证表明,靶向FABP5、FABP6、LPCAT1、MET、SEMA5B、SH3GL1、SNX33和RHBDF2的增强子具有致癌性。在类器官和动物模型中的进一步研究证明FABP5是一种癌基因。缺氧诱导因子-2α(HIF-2α)和锌指蛋白692(ZNF692)转录因子通过直接结合其启动子和增强子来调节FABP5的表达。FABP5对于HIF驱动的脂滴形成至关重要,并且对ccRCC细胞中的H3K27ac和增强子活性至关重要。因此,该研究确定了药物设计和诊断的潜在靶点,并发现了ccRCC中由FABP5调节的表观遗传学与脂质代谢之间反馈环的功能。